Through education, consensus building  and advocacy, the Best Medicines Coalition addresses issues related to pharmaceutical regulatory review, assessment, reimbursement and supply Coalition positions are communicated to policy decision makers and stakeholders in a range of ways including through submissions to formal consultations, representation on advisory bodies, development and distribution of position documents, correspondence, meetings and presentations.